Abstract
Oral cancer, mainly represented by the squamous cell carcinoma (OSCC), is globally the 10th most prevalent cancer worldwide, with a global annual incidence of approximately 300,000 new cases. Despite advances in the diagnosis and treatment options, the prognosis of patients with OSCC has remained virtually unchanged over recent decades, remaining at 50% over 5 years. Therefore, the identi…